It seems that the high expression of the CTLA-4 molecule in both Hodgkin’s lymphoma and CLL significantly influences the biology and mechanisms of cellular immune disorders in these diseases [36]. This evidence concerns the gene CTLA4 and Hodgkins lymphoma.